| Disease Specific Interactions between Host Protein and DME (HOSPPI) |
| ICD Disease Classification 02 Neoplasms |
| ICD-11: 2C12 Liver cancer |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
| Non-coding RNA regulation |
| hsa-miR-29a-3p |
Liver cancer |
Suppression |
| miRBase ID |
|
| Interaction Name |
hsa-miR-29a-3p--ALDH5A1 regulation |
[1] |
| Studied Cell Lines |
HepaRG cell line |
| Description |
hsa-miR-29a-3p is reported to suppress ALDH5A1 mRNA translation by binding to the 3' untranslated region (3'UTR) of ALDH5A1 mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Succinate-semialdehyde dehydrogenase. |
| ICD-11: 2C25 Lung cancer |
Click to Show/Hide the Full List of HOSPPI: 2 HOSPPI
|
| Non-coding RNA regulation |
| hsa-miR-147b |
Lung cancer |
Suppression |
| miRBase ID |
|
| Interaction Name |
hsa-miR-147b--ALDH5A1 regulation |
[2] |
| Studied Cell Lines |
A549 cell line |
| Description |
hsa-miR-147b is reported to suppress ALDH5A1 mRNA translation by binding to the 3' untranslated region (3'UTR) of ALDH5A1 mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Succinate-semialdehyde dehydrogenase. |
| hsa-miR-210-3p |
Lung cancer |
Suppression |
| miRBase ID |
|
| Interaction Name |
hsa-miR-210-3p--ALDH5A1 regulation |
[2] |
| Studied Cell Lines |
A549 cell line |
| Description |
hsa-miR-210-3p is reported to suppress ALDH5A1 mRNA translation by binding to the 3' untranslated region (3'UTR) of ALDH5A1 mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Succinate-semialdehyde dehydrogenase. |
|
|
|
|
|
|
